Pharma News

Gilead and Galapagos’ application seeking approval for their oral JAK1 inhibitor filgotinib as a treatment for ulcerative colitis has been validated by the European Medicines Agency (EMA).

NASHUA, N.

Novo Nordisk’s obesity management treatment Saxenda (liraglutide) has been recommended for use by the UK’s National Institute for Health and Care Excellence (NICE).

JERUSALEM, Nov.

Monday, 2nd November 2020 - Today Pfizer is announcing approximately €300 million capital investment in its Irish operations which will support the further development of existing manufacturing site...

Less than a month after the failure of a Phase III Duchenne muscular dystrophy trial (DMD), Switzerland-based Santhera Pharmaceuticals has announced a corporate restructuring that includes the...

LONDON (Reuters) - Britain will launch a COVID-19 mass testing pilot scheme in the northwest city of Liverpool this week, offering everyone tests whether or not they have symptoms, in an attem...

WASHINGTON (Reuters) - The U.

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

PerkinElmer has moved to expand its life sciences portfolio with CRISPR and gene editing offerings by snapping up the cell engineering specialist Horizon Discovery.

Lung cancer diagnosis and treatment are tough enough in the best of times.

Sanofi has entered into a deal to buy Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of...